Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Outstanding
Ratios

BioCorRx (BICX) Long-Term Debt Issuances (2016 - 2025)

Historic Long-Term Debt Issuances for BioCorRx (BICX) over the last 14 years, with Q3 2025 value amounting to $95000.0.

  • BioCorRx's Long-Term Debt Issuances fell 7351.02% to $95000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 5047.59%. This contributed to the annual value of $931502.0 for FY2024, which is 5525.03% up from last year.
  • Per BioCorRx's latest filing, its Long-Term Debt Issuances stood at $95000.0 for Q3 2025, which was down 7351.02% from $214600.0 recorded in Q2 2025.
  • In the past 5 years, BioCorRx's Long-Term Debt Issuances ranged from a high of $633100.0 in Q1 2025 and a low of $505.0 during Q2 2023
  • For the 5-year period, BioCorRx's Long-Term Debt Issuances averaged around $246371.6, with its median value being $235663.5 (2023).
  • Per our database at Business Quant, BioCorRx's Long-Term Debt Issuances skyrocketed by 690910.89% in 2024 and then crashed by 7351.02% in 2025.
  • Over the past 5 years, BioCorRx's Long-Term Debt Issuances (Quarter) stood at $300000.0 in 2021, then grew by 18.33% to $355000.0 in 2022, then decreased by 27.68% to $256727.0 in 2023, then soared by 31.45% to $337477.0 in 2024, then crashed by 71.85% to $95000.0 in 2025.
  • Its Long-Term Debt Issuances was $95000.0 in Q3 2025, compared to $214600.0 in Q2 2025 and $633100.0 in Q1 2025.